Real-Time News (current) FIRE NOW SIP Calculators
Easy-to-understand Financial Insights
that build Wealth.
Suit Of Products

Biocon Pharma Gets NMPA Approval for Tacrolimus Capsules, Expanding Its Drug Portfolio in China

Jan. 2, 2025, 6:07 p.m.
  • Biocon Pharma Limited has received approval from the National Medical Products Administration (NMPA) in China for Tacrolimus capsules in 0.5mg, 1mg, and 5mg strengths.
  • Tacrolimus is a…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

Learn More
BIOCON Corporate Action
BIOCON PRIOR FILINGS
ALL LATEST FILINGS